KZIA (Kazia Therapeutics) Insider Ownership: 0.01 % (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KZIA Kazia Therapeutics Ltd KZIA
33 GF Score
Price $10.20
! 5 Warning Signs
View Full Analysis

What is Kazia Therapeutics Insider Ownership?

Kazia Therapeutics KZIA -1.73% 33 Insider Ownership is 0.01 % as of Sep. 16, 2026. GuruFocus rates KZIA with a GF Score™ of 33/100. The stock has 5 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kazia Therapeutics's insider ownership is 0.01%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kazia Therapeutics's Institutional Ownership is 31.85%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kazia Therapeutics's Float Percentage Of Total Shares Outstanding is 99.92%.

Kazia Therapeutics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Kazia Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kazia Therapeutics Insider Ownership Chart

Kazia Therapeutics Historical Data

The historical data trend for Kazia Therapeutics can be seen below:

2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31
Insider Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
KZIA
33GF Score
Kazia Therapeutics Ltd KZIA
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kazia Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.01 % mean?
Kazia Therapeutics (KZIA) has a Insider Ownership of 0.01 % as of Sep. 16, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Kazia Therapeutics and its competitors.
Is Kazia Therapeutics' Insider Ownership too high?
Kazia Therapeutics' current Insider Ownership is 0.01 %. Overall, Kazia Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Kazia Therapeutics' Insider Ownership compare to OKUR and TNYA?
Kazia Therapeutics' Insider Ownership of 0.01 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Kazia Therapeutics and its competitors. Kazia Therapeutics's current Insider Ownership is 0.01 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kazia Therapeutics stock overvalued right now?
Kazia Therapeutics (KZIA) has a current Insider Ownership of 0.01 %. The current Insider Ownership is 0.01 %. Kazia Therapeutics' overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Kazia Therapeutics (KZIA), the current Insider Ownership is 0.01 % as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kazia Therapeutics Business Description

Address 300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
33GF Score

Get the complete analysis for KZIA

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.20
Price